BIA-ALCL was included as a new entity in the current WHO classification as a NHL characterized by a monoclonal population of large anaplastic cells which are uniformly CD30-positive and ALK negative and variably expressing T cell markers and EMA [9]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.